iCARE Salmonella Typhi & Paratyphi Antigen Rapid Test Kit
WHO-Standard Typhoid & Paratyphoid Rapid Diagnostic Test Kit
JAL Medical is a leading Manufacturer, Exporter & Supplier of the iCARE Salmonella Typhi & Paratyphi Antigen Rapid Test Kit (Feces) from Singapore to government healthcare agencies, hospitals, NGOs, and bulk distributors across Africa, Asia, the Caribbean, and Central Asia. This rapid typhoid antigen test simultaneously detects Salmonella Typhi AND Paratyphi (types A, B, and C) antigens directly from human fecal specimens – delivering clinically reliable results in just 15–20 minutes without laboratory equipment.
Unlike many competitor typhoid test kits that detect only S. Typhi, the iCARE test provides dual pathogen coverage in a single, cost-effective cassette – a critical advantage in regions where Paratyphi A is now the second most prevalent cause of enteric fever.
Key Product Specifications – iCARE Salmonella Typhi Paratyphi Antigen Test
| Specification | Detail |
| Product Name | iCARE Salmonella Typhi/Paratyphi Antigen Rapid Test |
| Brand | iCARE ADVANCED |
| Detection Targets | S. Typhi AND Paratyphi A, B & C Antigens (Feces) |
| Specimen Type | Human fecal (stool) specimen |
| Methodology | Lateral flow chromatographic immunoassay (colloidal gold) |
| Result Time | 15–20 minutes |
| Pack Sizes | 1, 2, 5, 7, 10, 20, 25, 40 Tests/Kit |
| Storage Temperature | 2–30°C (No cold chain / no freezing required) |
| Shelf Life | 24 months from date of manufacture |
| Intended Use | Professional in vitro diagnostic (IVD) use |
| Certification | CE marked; ISO 13485:2016; GMP certified manufacturing |
Clinical Performance: Proven Accuracy for Typhoid & Paratyphoid Fever Diagnosis
The iCARE Salmonella Typhi/Paratyphi Antigen Rapid Test has been validated against a reference RT-PCR assay using clinical fecal specimens from symptomatic, culture-positive patients (first week of illness).
| Performance Metric | Result |
| S. Typhi – Sensitivity | 98.03% (95% CI: 93.13%–99.46%) |
| S. Typhi – Specificity | 99.50% (95% CI: 97.22%–99.91%) |
| S. Typhi – Overall Accuracy | 99.00% |
| Paratyphi – Sensitivity | 98.00% (95% CI: 89.50%–99.65%) |
| Paratyphi – Specificity | 99.54% (95% CI: 97.47%–99.92%) |
| Paratyphi – Overall Accuracy | 99.25% |
| Cross-Reactivity | None with Rotavirus, Adenovirus, H. Pylori, Cholera |
How to Perform the Salmonella Typhi Antigen Rapid Test – Step-by-Step Protocol
- Equilibrate the test device, specimen collection tube, and extracted sample to room temperature (15–30°C).
- Collect a random fecal sample; stab the collection stick into the specimen at ≥5 different sites (do not scoop).
- Screw the stick into the tube; shake vigorously to extract Typhi/Paratyphi antigens into the buffer.
- Remove the test device from the foil pouch; place on a clean, level surface; label with patient ID.
- Add 2 drops (70–90 µL) of extracted specimen to the specimen well (S). Start the timer immediately.
- Read results at 15–20 minutes: Two lines (C + T) = Positive; C line only = Negative; No C line = Invalid.
Why to Choose iCARE Typhoid Antigen Test Kits?
- Dual Detection: Typhi + Paratyphi A, B & C in a single fecal antigen test – unmatched diagnostic coverage
- No Laboratory Equipment Needed: Ideal for field clinics, district hospitals, refugee camps, and primary care
- Active Infection Detection: Fecal antigen testing confirms current infection, not past exposure
- No Cold Chain Required: 2–30°C storage simplifies logistics to tropical and remote destinations
- Flexible Pack Sizes: 1–40 tests/kit supports pilot orders to large-scale national programme supply
- 24-Month Shelf Life: Supports long procurement cycles for government and UN tenders
- Export to 57+ African Countries + Caribbean + Central Asia via JAL Medical
Global Supply: Export Destinations & Procurement Partners
JAL Medical exports iCARE Rapid Diagnostic Test Kits to over 57 African countries including Nigeria, Ethiopia, Egypt, South Africa, Kenya, DR Congo, Uganda, Sudan, Ghana, Tanzania, Algeria, and Morocco, as well as to Caribbean nations and Central Asian countries. JAL Medical participates in WHO-backed tenders and UN procurement frameworks and provides full regulatory documentation for national registration.
Frequently Asked Questions on iCARE Salmonella Typhi & Paratyphi Antigen Rapid Test Kit
Does this test detect both Salmonella Typhi AND Paratyphi in one test?
Yes. The iCARE Salmonella Typhi/Paratyphi Antigen Rapid Test detects both S. Typhi and S. Paratyphi (types A, B, and C) antigens from a single fecal specimen - providing comprehensive enteric fever coverage unavailable in most other rapid typhoid tests on the market.
What specimen type is used, and is blood collection required?
No blood collection is required. The test uses a human fecal (stool) specimen collected using the provided specimen collection tube with extraction buffer. This eliminates biosafety risks associated with blood collection and is particularly suitable for community, pediatric, and field settings.
What is the clinical sensitivity and specificity?
The test achieves 98.03% sensitivity and 99.50% specificity for S. Typhi, and 98.00% sensitivity and 99.54% specificity for Paratyphi - both validated against a reference RT-PCR assay using culture-confirmed clinical specimens.
What certifications and quality documents are available for regulatory submissions?
JAL Medical provides CE certificates, ISO 13485:2016 certification, GMP compliance documentation, IFU (Instructions for Use) in multiple languages, and performance data summaries to support national regulatory registration in buyer countries.
What pack sizes are available, and what is the minimum order quantity?
Pack sizes range from 1 to 40 Tests/Kit. Minimum order quantities vary by country and buyer type. Contact JAL Medical at www.jalmedical.com for country-specific pricing, MOQ, and bulk procurement terms.
Does the test require cold chain management during shipping?
No. The test is stable at 2–30°C with no cold chain requirement. This significantly simplifies logistics and reduces costs for shipments to tropical and remote destinations in Africa, Asia, and the Caribbean.
Is this test suitable for outbreak response and field use?
Yes. The self-contained format requires no laboratory equipment, electricity, or refrigeration at the point of testing. Results in 15–20 minutes enable same-visit treatment decisions - ideal for typhoid outbreak response, mobile health units, and humanitarian field programs.